David Capper

42.7k total citations · 5 hit papers
230 papers, 13.4k citations indexed

About

David Capper is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, David Capper has authored 230 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Genetics, 108 papers in Molecular Biology and 60 papers in Cancer Research. Recurrent topics in David Capper's work include Glioma Diagnosis and Treatment (133 papers), Epigenetics and DNA Methylation (27 papers) and Cancer Genomics and Diagnostics (26 papers). David Capper is often cited by papers focused on Glioma Diagnosis and Treatment (133 papers), Epigenetics and DNA Methylation (27 papers) and Cancer Genomics and Diagnostics (26 papers). David Capper collaborates with scholars based in Germany, United States and Switzerland. David Capper's co-authors include Andreas von Deimling, Christian Hartmann, Pieter Wesseling, Wolfgang Wick, Stefan M. Pfister, Michael Weller, Christel Herold‐Mende, Jochen Meyer, Guido Reifenberger and Matthias Preusser and has published in prestigious journals such as Cell, The Lancet and Journal of Clinical Investigation.

In The Last Decade

David Capper

217 papers receiving 13.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

2009 868 citations Christian Hartmann, Jörg Balß et al. Acta Neuropathologica profile →
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

2011 739 citations David Capper, Pieter Wesseling et al. Acta Neuropathologica profile →
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

2010 627 citations Christian Hartmann, Bettina Hentschel et al. Acta Neuropathologica profile →
WHO 2016 Classification of gliomas

2017 570 citations Pieter Wesseling, David Capper profile →
Primary brain tumours in adults

2023 157 citations Martin J. van den Bent, Pim J. French et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Capper Germany	58	7.8k	5.2k	3.4k	2.6k	2.5k	230	13.4k
Johannes A. Hainfellner Austria	51	7.5k 1.0×	6.0k 1.2×	3.1k 0.9×	2.4k 0.9×	3.1k 1.2×	297	14.9k
Marc Sanson France	61	8.6k 1.1×	5.2k 1.0×	3.8k 1.1×	1.8k 0.7×	3.1k 1.2×	319	14.1k
Karima Mokhtari France	57	7.2k 0.9×	3.3k 0.6×	2.6k 0.8×	1.6k 0.6×	2.6k 1.0×	234	10.7k
Jürgen Curschmann Switzerland	7	10.6k 1.4×	5.4k 1.0×	3.5k 1.0×	2.9k 1.1×	3.8k 1.5×	11	16.3k
Tom Mikkelsen United States	71	9.9k 1.3×	6.4k 1.2×	4.2k 1.2×	4.1k 1.6×	4.3k 1.7×	258	18.9k
Nicolas de Tribolet Switzerland	56	7.0k 0.9×	6.2k 1.2×	3.1k 0.9×	3.9k 1.5×	2.6k 1.0×	189	16.4k
Andrew E. Sloan United States	56	6.1k 0.8×	4.3k 0.8×	2.6k 0.8×	4.1k 1.6×	3.5k 1.4×	225	14.0k
Peter Hau Germany	43	6.9k 0.9×	5.1k 1.0×	3.2k 0.9×	2.8k 1.1×	2.2k 0.9×	189	11.9k
Kurt A. Jaeckle United States	54	6.6k 0.8×	3.3k 0.6×	1.7k 0.5×	2.7k 1.1×	4.3k 1.7×	160	11.4k
Hai Yan United States	37	5.5k 0.7×	7.1k 1.4×	4.6k 1.4×	2.2k 0.9×	2.0k 0.8×	91	12.5k

Countries citing papers authored by David Capper

Since Specialization

Citations

This map shows the geographic impact of David Capper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Capper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Capper more than expected).

Fields of papers citing papers by David Capper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Capper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Capper. The network helps show where David Capper may publish in the future.

Co-authorship network of co-authors of David Capper

This figure shows the co-authorship network connecting the top 25 collaborators of David Capper. A scholar is included among the top collaborators of David Capper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Capper. David Capper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aldape, Kenneth, David Capper, Andreas von Deimling, et al.. (2025). cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics. Neuro-Oncology Advances. 7(1). vdae228–vdae228. 9 indexed citations

Engelhardt, Melina, Ulrike Grittner, Lisa Fischer, et al.. (2025). Analysis of Neuronal Excitability Profiles for Motor-Eloquent Brain Tumor Entities Using nTMS in 800 Patients. Cancers. 17(6). 935–935.

Ehret, Felix, Eilís Pérez, Daniel Teichmann, et al.. (2024). Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas. Acta Neuropathologica Communications. 12(1). 74–74. 3 indexed citations

Simon, Michèle, Luis P. Kuschel, Katja von Hoff, et al.. (2024). Rapid DNA methylation-based classification of pediatric brain tumors from ultrasonic aspirate specimens. Journal of Neuro-Oncology. 169(1). 73–83. 2 indexed citations

Pérez, Eilís, Salvatore Benfatto, Martin Sill, et al.. (2024). Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice. Bioinformatics. 40(2). 23 indexed citations

Capper, David, Guido Reifenberger, Pim J. French, et al.. (2023). EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. Neuro-Oncology. 25(5). 813–826. 54 indexed citations

Zhu, Tianyu, Jacklyn Liu, Stephan Beck, et al.. (2022). A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution. Nature Methods. 19(3). 296–306. 57 indexed citations

Drexler, Richard, Ulrich Schüller, Katharina Filipski, et al.. (2022). DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients. Neuro-Oncology. 25(2). 315–325. 37 indexed citations

Jurmeister, Philipp, Inga Hoffmann, Claudia Vollbrecht, et al.. (2021). Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations. The Journal of Pathology. 256(1). 61–70. 20 indexed citations

10.

Wang, Anthony, David Jones, Bonnie Cole, et al.. (2018). Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations. Molecular Cancer Research. 16(10). 1491–1498. 37 indexed citations

11.

Witt, Hendrik, Dorothee Gramatzki, Bettina Hentschel, et al.. (2018). DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment. Neuro-Oncology. 20(12). 1616–1624. 59 indexed citations

12.

Huse, Jason T., Matija Snuderl, David Jones, et al.. (2016). Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathologica. 133(3). 417–429. 162 indexed citations

13.

Ilié, Marius, Sandra Lassalle, Élodie Long-Mira, et al.. (2014). Diagnostic Value of Immunohistochemistry for the Detection of the BRAF ^V600E Mutation in Papillary Thyroid Carcinoma: Comparative Analysis with Three DNA-Based Assays. Thyroid. 24(5). 858–866. 51 indexed citations

14.

Bauer, Jürgen, Annette Pflugfelder, Friedegund Meier, et al.. (2014). Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients with Primary Melanoma. PLoS ONE. 9(1). e86194–e86194. 38 indexed citations

15.

Preusser, Matthias, Anna S. Berghoff, Aysegül Ilhan‐Mutlu, et al.. (2013). Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies.. PubMed. 33(3). 1065–71. 18 indexed citations

16.

Andrulis, Mindaugas, Nicola Lehners, David Capper, et al.. (2013). Targeting the BRAF V600E Mutation in Multiple Myeloma. Cancer Discovery. 3(8). 862–869. 171 indexed citations

17.

Bid, Hemant K., Doris A. Phelps, Linlin Xiao, et al.. (2013). Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma. Clinical Cancer Research. 19(24). 6716–6729. 49 indexed citations

18.

Preusser, Matthias, Anna S. Berghoff, David Capper, et al.. (2013). No Evidence for BRAF-V600E Mutations in Gastroeosophageal Tumors. Applied immunohistochemistry & molecular morphology. 21(5). 426–430. 14 indexed citations

19.

Long, Georgina V., James S. Wilmott, David Capper, et al.. (2012). Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma. The American Journal of Surgical Pathology. 37(1). 61–65. 224 indexed citations

20.

Capper, David, Hanswalter Zentgraf, Jörg Balß, Christian Hartmann, & Andreas von Deimling. (2009). Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathologica. 118(5). 599–601. 316 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact